Publications by authors named "Heidi Gray"

Claim this Profile
A
A phase 2 trial of niraparib plus bevacizumab maintenance therapy following first-line platinum-based chemotherapy with bevacizumab in advanced ovarian cancer: final analysis and overall survival results from OVARIO.
Melissa M Hardesty, Thomas C Krivak, Gail S Wright, Erika Hamilton, Evelyn L Fleming, Heidi J Gray

Gynecol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'It's Putting All the Burden on the Patient': A Qualitative Study of Health Literacy and Shared Decision-Making in Rural Australian Communities.
Heidi Gray, Tiana Kittos, Danielle M Muscat

Aust J Rural Health· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial access.
Ann Oluloro, Elizabeth M Swisher, Heidi J Gray, Barbara Goff, Kemi M Doll

J Natl Cancer Inst· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of cognitive remediation therapy for improving the communication capabilities of adults with schizophrenia and other psychotic spectrum disorders.
Anna McGuiness, Lara Travethan, Kylie Irvin, Yvette Black, Jessica Apps, Heidi Gray

Int J Lang Commun Disord· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.
Joyce Liu, Andrew Berchuck, Floor J Backes, Joshua Cohen, Rachel Grisham, Heidi J Gray

J Natl Compr Canc Netw· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparison of Voice and Psychotherapeutic Treatments for Adults With Functional Voice Disorders: A Systematic Review.
Heidi Gray, Leah Coman, Chloe Walton, Sarah Thorning, Elizabeth Cardell

J Voice· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma.
Tracy T Batchelor, Minhee Won, Arnab Chakravarti, Costas G Hadjipanayis, Wenyin Shi, Heidi J Gray

Neurooncol Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
Aaron M Praiss, Austin Miller, Judith Smith, Stuart M Lichtman, Michael Bookman, Heidi Gray

Gynecol Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study.
Tiffany Y Sia, William P Tew, Christopher Purdy, Dennis S Chi, Andrew W Menzin, Heidi J Gray

Gynecol Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Intensive Voice Therapy Versus Weekly Therapy for Muscle Tension Dysphonia: A Noninferiority Randomised Controlled Trial With Nested Focus Group.
Rachel Wenke, Leah Coman, Chloe Walton, Catherine Madill, Deborah Theodoros, Heidi Gray

J Voice· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing.
Heidi J Gray, Payel Chatterjee, Rachele Rosati, Lauren R Appleyard, Grace J Durenberger

NPJ Precis Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clitoral metastasis of vulvar melanoma treated with talimogene laherparepvec.
Erin M McClure, Neha Singh, Kim G Abson, Shailender Bhatia, Heidi J Gray

JAAD Case Rep· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.
Talayeh S Ghezelayagh, Emily S Wu, Emma L Barber, Minh D Dao, Emese Zsiros, Heidi J Gray

Eur J Gynaecol Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Participation of Patients With Limited English Proficiency in Gynecologic Oncology Clinical Trials.
Soledad Jorge, Shatreen Masshoor, Heidi J Gray, Elizabeth M Swisher, Kemi M Doll

J Natl Compr Canc Netw· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uterine lavage identifies cancer mutations and increased somatic mutation burden in individuals with ovarian cancer.
Talayeh S Ghezelayagh, Brendan F Kohrn, Jeanne Fredrickson, Enna Manhardt, Marc R Radke, Heidi J Gray

Cancer Res Commun· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, Jamie N Bakkum-Gamez, Lisa Barroilhet, Heidi J Gray

J Natl Compr Canc Netw· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab.
Melissa M Hardesty, Thomas C Krivak, Gail S Wright, Erika Hamilton, Evelyn L Fleming, Heidi J Gray

Gynecol Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The optimal management of brain metastases from gestational trophoblastic neoplasia.
Joseph Tsai, Balamurugan Vellayappan, Vyshak Venur, Tresa McGranahan, Heidi Gray

Expert Rev Anticancer Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive skill training improves memory, function, and use of cognitive strategies in cancer survivors.
Monique M Cherrier, Celestia S Higano, Heidi J Gray

Support Care Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Early Years of Bevacizumab Use for First-Line Treatment of Ovarian Cancer in the United States.
Soledad Jorge, Barbara A Goff, Heidi J Gray, Daniel A Enquobahrie, Kemi M Doll

JCO Oncol Pract· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival.
Lari Wenzel, Kathryn Osann, Chelsea McKinney, David Cella, Giulia Fulci, Heidi J Gray

J Natl Cancer Inst· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Society of Gynecologic Oncology (SGO) 2021 meeting report: Scaling new heights with innovative cancer care.
Heidi J Gray, Angeles Alvarez Secord

Gynecol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study.
Jessica Gillen, Austin Miller, Katherine M Bell-McGuinn, Russell J Schilder, Joan L Walker, Heidi J Gray

Gynecol Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).
Megan E Buechel, Danielle Enserro, Robert A Burger, Mark F Brady, Katrina Wade, Heidi Gray

Gynecol Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, Lisa Barroilhet, Kian Behbakht, Heidi J Gray

J Natl Compr Canc Netw· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis